Cite
MLA Citation
Alexander M M Eggermont et al.. “Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.” Lancet oncology, vol. 22, no. 5, 2021, pp. 643–654. http://access.bl.uk/ark:/81055/vdc_100129543947.0x00000c